Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

The Adventurers - Fighting the war on childhood cancer

Elliot's life was stolen by brain cancer when he was only 4 years old, so his parents channeled their sorrow by setting up the Telethon Adventurers. Read more.

All through the night

For the parent of a child living with diabetes, sleep no longer represents the relaxing slumber that it used to.

A tight circle of support - the family and friends of Ethan Davies

The Ethan Davies Scholarship is a community fundraising campaign started by Christie-Lee & Shannon Davies after their son Ethan was diagnosed with brain cancer

Onwards and upwards

Making FASD History inspires the rest of the world to follow suit.

Partnership with BHP proves a game changer for the Institute

What does BHP know about medical research? More than you might imagine!

Research

An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy

The vascular endothelial growth factors and their receptors are key regulators of blood vessel formation, including in tumors, where their deregulated function can promote the production of aberrant, leaky blood vessels, supporting tumor development. 

Research

Towards Harmonized Adolescent Health Measurement: Assessing Alignment Between Current Recommendations and the Global Action for Measurement of Adolescent Health–Recommended Indicators

This study identified alignment of indicators across different initiatives and data collection instruments as a foundation for future harmonization of adolescent health measurement.

Research

High-flow nasal oxygen for children's airway surgery to reduce hypoxaemic events: a randomised controlled trial

Tubeless upper airway surgery in children is a complex procedure in which surgeons and anaesthetists share the same operating field. These procedures are often interrupted for rescue oxygen therapy. 

Research

Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial

Bronchiectasis is a worldwide chronic lung disorder where exacerbations are common. It affects people of all ages, but especially Indigenous populations in high-income nations. Despite being a major contributor to chronic lung disease, there are no licensed therapies for bronchiectasis and there remain relatively few randomised controlled trials (RCTs) conducted in children and adults.

Research

Patient preferences for prophylactic regimens requiring regular injections in children and adolescents: A systematic review and thematic analysis

At present, limited literature exists exploring patient preferences for prophylactic treatment of acute rheumatic fever and rheumatic heart disease. Given low treatment completion rates to this treatment in Australia, where the burden of disease predominantly affects Aboriginal and Torres Strait Islander people, an improved understanding of factors driving patient preference is required to improve outcomes.